Hetero Launches Generic Semaglutide Brands Truglyx, Rolmodl, Moto G Across 75+ Countries sheeba farhat28 March 2026 8:22 PM ISTNew Delhi: Hetero has announced the export launch of its generic semaglutide portfolio, marking a significant step toward expanding access to GLP-1...
Medical Bulletin 28/March/2026 Anshika Mishra28 March 2026 3:00 PM ISTHere are the top medical news for today: Study Links Obesity-Driven Organ Enlargement to Increased Risk of Cancer Development Scientists at City of...
New Study Reveals How Obesity Drives Cancer Risk by Increasing Cell Numbers Anshika Mishra28 March 2026 8:00 AM ISTScientists at City of Hope and Translational Genomics Research Institute have identified a key biological mechanism explaining how obesity increases...
Later sleep and wake times tied to poor diet and sedentary behavior in teens, suggests study Dr. Kamal Kant Kohli27 March 2026 9:00 PM ISTWhen people think about ways to improve cardiovascular health, diet and exercise are often at the top of the list. But long-term health, especially in...
CVD Linked to Increased nonmelanoma skin cancer Risk via Obesity and Inflammation: Study Dr. Shravani Dali25 March 2026 10:00 PM ISTResearchers have found in a new study that cardiovascular disease (CVD) is associated with a higher risk of developing nonmelanoma skin cancer (NMSC),...
Combination GLP-1 therapy shows fat mass loss while preserving lean mass in adults with obesity: Study Dr. Kamal Kant Kohli25 March 2026 9:00 PM ISTA recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that blocks activin signaling...
Extra belly weight, not BMI stronger predictor of heart failure risk, inflammation: Study Dr. Kamal Kant Kohli25 March 2026 8:30 AM ISTNew research suggests that measures of excess weight around the waist (central obesity or visceral fat) may increase the risk of heart failure...
TRIUMPH Program Showcases Retatrutide's Potency of 24 Percent Weight Loss: Study Finds Aashi verma24 March 2026 9:00 PM ISTThe TRIUMPH program's innovative approach suggests that retatrutide could offer a clinical breakthrough in managing obesity-related morbidity by...
Researchers find link between ultra-processed foods and infertility in US women Dr. Kamal Kant Kohli24 March 2026 8:45 PM ISTWomen who consume lower amounts of ultra-processed foods have higher odds of conceiving, according to new research from McMaster University. The link...
GLP-1 Drugs Improve Metabolic Outcomes in Cushing's Syndrome Without Hormonal Harm: Study Dr Riya Dave24 March 2026 8:45 AM ISTResearchers have discovered in a new study that among patients with Cushing's syndrome, treatment with GLP-1 drugs led to significant weight loss and...
Adolescent Obesity Crisis Reaches 21.7 Percent in India: Study Finds Aashi verma23 March 2026 8:45 PM ISTWith an alarming 21.7% of urban adolescents now identified as being either overweight or obese, these metabolic trajectories solidify into adult...
GLP-1 Medications May Improve Anxiety and Depression Symptoms, suggests study Dr. Kamal Kant Kohli19 March 2026 8:30 PM ISTGLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness absence due to psychiatric...
